MedTrace Logo

A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients

NCT04591028 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2023-07-19

No results posted yet for this study

Summary

This study will be looking at the safety and added benefit of using the Indocyanine green dye (ICG) during surgery.

Conditions

Interventions

DRUG

Indocyanine green

A one time injection of IDC prior to the day of scheduled surgery.

Sponsors & Collaborators

Principal Investigators

  • Enrique F Elli, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2022-01-31
Completion
2022-08-10
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04591028 on ClinicalTrials.gov